Hepatology APC and Open Access: Latest Public LWW Fee Schedule, Coverage, and Fit
Hepatology APC uses the latest public LWW fee schedule: $3,510 CC BY-NC-ND or $3,900 CC BY. Coverage, metrics, and fit.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Hepatology publishing costs and open access options
APC is one cost. Funder mandates, institutional agreements, and access route timing all shape what you actually pay.
What shapes what you pay
- Hepatology offers open access publishing. Check whether your institution has a read-and-publish agreement.
- Funder mandates (NIH, Wellcome, UKRI) may require immediate OA — verify compliance before choosing a subscription route.
- Accepted authors typically have 48-72 hours to choose their access route before proofs begin.
When OA is worth the cost
- When your funder or institution requires it — non-compliance can affect future funding.
- When your topic benefits from broad immediate access beyond institutional subscribers.
- Hepatology's IF 15.8 means OA papers here have real citation upside.
Quick answer: Hepatology APC is one of the cleaner pages to ground because the journal's official submission instructions expose a real fee schedule. As of April 21, 2026, the latest public Hepatology open-access schedule I could verify is the 2025 fee table in the journal's official Editorial Manager instructions: $3,510 for CC BY-NC-ND and $3,900 for CC BY. Hepatology remains a hybrid journal, so the subscription route is still $0. For the hub, see the Hepatology journal page.
Hepatology APC at a glance
Item | Current position |
|---|---|
Journal model | Hybrid |
Latest public CC BY-NC-ND APC | $3,510 |
Latest public CC BY APC | $3,900 |
Subscription route | $0 |
Payment timing | After acceptance |
2024 impact factor | 15.8 |
5-year JIF | 14.5 |
JIF without self-cites | 15.2 |
JCI | 3.18 |
SJR 2024 | 5.557 |
H-index | 415 |
JCR rank | 7/147 |
If the fee looks manageable, the real risk is still editorial fit. A Hepatology desk-rejection risk check is the useful first step, not the payment workflow.
What the current official source actually says
The most useful verified source here is the journal's own official Editorial Manager instructions. Those instructions state:
- open access is optional
- the APC is charged on acceptance
- payment must be completed for the article to publish OA
- the latest public fee schedule exposed there is:
- $3,510 for CC BY-NC-ND
- $3,900 for CC BY
That matters because many generic APC aggregators still float older or wrong Hepatology numbers.
It also resolves the publisher question for this page: the verified OA workflow is being handled through the journal's Wolters Kluwer and LWW pathway, not through a Wiley-style hybrid charge flow.
Metrics context behind the APC
Metric | Current figure | Why it matters |
|---|---|---|
Impact Factor | 15.8 | Hepatology remains one of the strongest liver-owned journals |
5-year JIF | 14.5 | Long-run citation profile stays strong |
JIF without self-cites | 15.2 | The citation signal is clean, not self-cite driven |
JCI | 3.18 | Field-normalized performance is strong |
SJR | 5.557 | Prestige-weighted influence is high for a specialty journal |
H-index | 415 | Archive authority is deep |
JCR rank | 7/147 | Clear Q1 position in Gastroenterology and Hepatology |
The practical message is straightforward: Hepatology is not charging flagship-general-medicine money. It is charging a premium specialty-journal hybrid APC for a liver-owned title with real field authority.
Long-run trend table
The JCR page gives the current impact factor. For longer directional context, the open Scopus-based impact-score series is the cleanest stable trend line available.
Year | Scopus impact score |
|---|---|
2014 | 8.04 |
2015 | 8.08 |
2016 | 8.12 |
2017 | 7.22 |
2018 | 6.99 |
2019 | 8.08 |
2020 | 9.41 |
2021 | 9.42 |
2022 | 8.89 |
2023 | 7.92 |
2024 | 9.55 |
Directionally, the open citation signal is positive. Hepatology is up from 7.92 in 2023 to 9.55 in 2024 on the Scopus impact-score line. That fits the broader picture of a journal that still has strong liver-field ownership.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
What authors actually need to decide
The real choices at Hepatology are:
Subscription route
- no APC
- still viable for authors without an immediate-OA mandate
Open-access route
- pay $3,510 for CC BY-NC-ND, or $3,900 for CC BY, using the latest verified public schedule
- usually the right move when funder rules require immediate OA or a library agreement covers the bill
Coverage and waiver reality
- institutional or consortium support may reduce or remove the author bill
- exact eligibility is publisher-side and institution-specific
- low-income-country or hardship support can matter more than authors initially expect
The useful planning rule is simple: treat the verified public schedule as the default, then check your library before assuming you will actually pay it.
How Hepatology compares with nearby liver and GI options
Journal | OA cost posture | 2024 citation profile | Practical comparison |
|---|---|---|---|
Hepatology | Hybrid, $3,510 or $3,900 on latest verified public schedule | IF 15.8, SJR 5.557 | Strong liver-owned flagship lane |
Journal of Hepatology | Hybrid, usually higher | Higher top-line IF | Better if the manuscript is cleaner for EASL readership |
Gut | Hybrid premium band | Stronger broad GI profile | Better when the story is broader GI, not purely liver-owned |
Clinical Gastroenterology and Hepatology | Hybrid | Lower prestige but strong practice relevance | Better for more practice-facing work |
Hepatology Communications | Fully OA sister lane | Lower citation tier | Cleaner OA path when the flagship bar is not realistic |
The important point is that Hepatology is not a generic GI prestige purchase. If the paper is truly liver-owned, the APC is easier to justify. If the paper only touches hepatology at the edges, the fee is the wrong thing to focus on.
What we see in pre-submission review work on Hepatology manuscripts
In our pre-submission review work, the APC becomes a mistake only after the fit mistake has already happened.
The repeat pattern is:
- a manuscript with a real liver angle
- but not enough liver ownership in the evidence package
- plus a submission plan driven by the journal name rather than the journal audience
That is why Hepatology APC planning should come after one harder question: would a hepatologist immediately recognize the manuscript as liver-first? If the answer is shaky, a quick submission readiness check is worth more than another hour comparing APC tables.
Submit if / Think twice if
Submit and consider the APC worthwhile if:
- the liver question is central and visible from page one
- the manuscript is competitive for a flagship liver journal
- your institution or funder can absorb the fee
- immediate OA has a real compliance or dissemination benefit
Think twice if:
- the liver framing is thinner than the cover letter suggests
- the manuscript is mostly a broader GI or translational story
- you would be paying personally without a mandate
- the cleaner owner journal is Hepatology Communications or another non-flagship venue
Practical verdict
For Hepatology APC, the current verified public answer is stronger than the old approximation-heavy version:
- hybrid journal
- $0 subscription route
- latest public official schedule verified in the journal instructions:
- $3,510 for CC BY-NC-ND
- $3,900 for CC BY
That is a real planning number. The only reason to ignore it is if your institution covers the bill.
Frequently asked questions
As of April 21, 2026, the latest publicly exposed official Hepatology schedule I could verify lists the 2025 APC at $3,510 for CC BY-NC-ND and $3,900 for CC BY.
No. Hepatology is a hybrid journal. Authors can still publish through the subscription route at $0 and only pay if they opt for open access.
The current verified OA workflow is handled through the journal's Wolters Kluwer and Editorial Manager pathway, with payment due after acceptance.
Sometimes. Coverage depends on publisher-side arrangements and institutional eligibility, so authors need to check with their library rather than assume general publisher coverage.
It makes the most sense when a funder or institution covers the bill and the paper is strong enough for Hepatology's liver-specific flagship editorial lane.
Sources
Before you upload
Want the full picture on Hepatology?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Hepatology Submission Guide: Scope, Format & Tips
- Is Hepatology a Good Journal? The AASLD Liver Flagship
- Hepatology Impact Factor 2026: 15.8, Q1, Rank 7/147
- Hepatology Acceptance Rate: What Authors Can Use
- How to Avoid Desk Rejection at Hepatology
- Hepatology Submission Process: What Happens After You Upload
Supporting reads
Conversion step
Want the full picture on Hepatology?
These pages attract evaluation intent more than upload-ready intent.